Variants

Variants

162 bookmarks
Custom sorting
Study reveals how SARS-CoV-2 variants of concern modulate receptor and antibody binding
Study reveals how SARS-CoV-2 variants of concern modulate receptor and antibody binding
In a trailblazing engineering effort, Canadian and US researchers indicate that the emergence of novel variants of SARS-CoV-2 stems from the mutations of spike glycoprotein that confer either increased affinity for the host cell receptor or increased antibody evasion.//30.8.2021
·news-medical.net·
Study reveals how SARS-CoV-2 variants of concern modulate receptor and antibody binding
Koronaviruksen uusi myy-variantti lisättiin WHO:n tarkkailulistalle – pelätään väistävän immuunipuolustusta
Koronaviruksen uusi myy-variantti lisättiin WHO:n tarkkailulistalle – pelätään väistävän immuunipuolustusta
Tammikuussa Kolumbiasta ensimmäistä kertaa löydetty myy-variantti on viides koronaviruksen muunnos, joka on luokiteltu ”huolta herättäväksi”. WHO:n mukaan tarvitaan lisätutkimusta, ennen kuin tiedetään, onko syytä todelliseen huoleen. //2.9.2021
·is.fi·
Koronaviruksen uusi myy-variantti lisättiin WHO:n tarkkailulistalle – pelätään väistävän immuunipuolustusta
Using infodemiology to understand symptoms of SARS-CoV-2 Lambda variant
Using infodemiology to understand symptoms of SARS-CoV-2 Lambda variant
A new variant (lineage C.37) initially identified in Lima, Peru, has since been classified as “Lambda” by the World Health Organization (WHO). The lambda variant was classified in June 2021 by the WHO as a “variant of interest.”
·news-medical.net·
Using infodemiology to understand symptoms of SARS-CoV-2 Lambda variant
Evolved SARS-CoV-2 viruses gain higher infectivity and cause more rapid infection spread
Evolved SARS-CoV-2 viruses gain higher infectivity and cause more rapid infection spread
Viruses accumulate mutations as they replicate in infected cells. Repeated replication can lead to viral strains that show attenuated virulence. Such strains may act as vaccines if the attenuated virus can produce immunity without serious disease.
·news-medical.net·
Evolved SARS-CoV-2 viruses gain higher infectivity and cause more rapid infection spread
Therapeutic potential of clinical-grade ACE2 for blocking SARS-CoV-2 variants
Therapeutic potential of clinical-grade ACE2 for blocking SARS-CoV-2 variants
According to new research by an international team of scientists, all SARS-CoV-2 variants, including variants of concern (VOC) Alpha, Beta, Gamma, and Delta, exhibit enhanced affinity toward recombinant human soluble ACE2.
·news-medical.net·
Therapeutic potential of clinical-grade ACE2 for blocking SARS-CoV-2 variants